Evidence map›Paper›PMID 34060822›Full record

ArticleJournal of the American Chemical Society2021

Microwave-Assisted Automated Glycan Assembly.

José Danglad-Flores, Sabrina Leichnitz, Eric T Sletten, A Abragam Joseph, Klaus Bienert, Kim Le Mai Hoang, Peter H Seeberger

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Glycan microarray analysis ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Journal of the American Society for Mass Spectrometry · 2025
    Article
  4. Automated Glycan Assembly ofJournal of the American Chemical Society · 2025
    Article
  5. Article
  6. Carbohydrate Synthesis is Entering the Data-Driven Digital Era.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  7. Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  8. Review
  9. Automated Synthesis of Algal Fucoidan Oligosaccharides.Journal of the American Chemical Society · 2024
    Article
  10. Article
  11. Article
  12. VaporSPOT: Parallel Synthesis of Oligosaccharides on Membranes.Journal of the American Chemical Society · 2022
    Article
  13. Design, Synthesis, and Characterization of Stapled Oligosaccharides.Journal of the American Chemical Society · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Danglad-FloresDepartment of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.
Sabrina LeichnitzDepartment of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.
Eric T SlettenDepartment of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.ORCID 0000-0003-2177-2969
A Abragam JosephDepartment of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.ORCID 0000-0003-3584-0408
Klaus BienertMax-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.
Kim Le Mai HoangGlycoUniverse GmbH & Co KGaA, Am Mühlenberg 11, 14476 Potsdam, Germany.
Peter H SeebergerDepartment of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces, 14476 Potsdam, Germany.ORCID 0000-0003-3394-8466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automated synthesis of DNA, RNA, and peptides provides quickly and reliably important tools for biomedical research. Automated glycan assembly (AGA) is significantly more challenging, as highly branched carbohydrates require strict regio- and stereocontrol during synthesis. A new AGA synthesizer enables rapid temperature adjustment from -40 to +100 °C to control glycosylations at low temperature and accelerates capping, protecting group removal, and glycan modifications using elevated temperatures. Thereby, the temporary protecting group portfolio is extended from two to four orthogonal groups that give rise to oligosaccharides with up to four branches. In addition, sulfated glycans and unprotected glycans can be prepared. The new design reduces the typical coupling cycles from 100 to 60 min while expanding the range of accessible glycans. The instrument drastically shortens and generalizes the synthesis of carbohydrates for use in biomedical and material science.

Identifiers

PMID34060822
PMCPMC8213053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.